Incontinix

Description of the article « Incontinix »

Quick Answer

Incontinix (sold as VigRX® Incontinix) is a bladder-control capsule formula for men from Leading Edge Health, built on the patented Urox® proprietary blend. Like its women's counterpart, it stands apart in this category because the maker reports an eight-week, double-blind, placebo-controlled trial of that exact blend at the exact dose in the bottle — 150 volunteers, published in BMC Complementary Medicine and Therapies, with urgency down 62% and leaks cut in half. The trial's sponsor and full citation are not published, the blend's per-ingredient amounts are not published, and the maker's marketing carries no safety or warnings section at all. We score it 7.5/10.

Quick Reference

Our Verdict

Incontinix has the evidence structure we wish every product in this store had: not ingredient folklore, but a reported trial of the product's entire active formula, at the dose the bottle delivers, measuring the outcomes sufferers actually care about — urgency, leaks, daytime frequency, night-time waking. It loses marks for everything around that trial. The maker publishes no sponsor, no full citation and no breakdown of who the 150 volunteers were; its "tested in 14 clinical trials" claim is supported by exactly one described trial; the blend's ingredient amounts are proprietary and unpublished; and a bladder product aimed at older men — many of them on prescription medication — carries no warnings or medication cautions anywhere in its marketing. Buy it for the trial-reported blend and the guarantee, and discuss it with a doctor if you take medication, because the maker won't raise the subject.

Sub-scores

• Ingredients: 7.5/10 — Only three actives, all named, in a patented blend delivered at the clinically used 840 mg total dose; but per-ingredient amounts are not published (proprietary blend), so no individual dose can be checked.
• Evidence: 8.5/10 — A blend-level, 8-week, double-blind, placebo-controlled human trial (150 volunteers as the maker states it, journal named, specific outcomes) at the exact product dose; docked because the maker publishes no sponsor or full citation, and the "14 trials" claim is supported by only one described trial.
• Maker credibility: 8.0/10 — Leading Edge Health, an established maker with a written 67-day guarantee and a verifiable U.S. patent number behind the blend; docked for typo-ridden store copy, an unnamed doctor endorsement on the brand page, and overclaiming on its secondary retail page.
• Safety: 6.5/10 — The maker reports no negative side effects in the studies, but publishes no warnings, exclusions or medication cautions on any marketing page; only generic label precautions exist.
• Value: 7.0/10 — $59.99 a bottle (about $2.00 a day); the 8-week trial course (2 bottles) fits inside the 67-day guarantee window, but multi-pack totals are not published as text and no pack larger than 3 bottles exists.

What Is Incontinix?

Incontinix is a daily capsule formula for men with a weak or overactive bladder — frequent daytime urges, waking at night to urinate, and leaks. All of the maker's marketing positions it for men only: the brand page headlines it a "Natural Bladder Control Solution for Men," and the maker frames the mechanism as strengthening the three elements of bladder control — the bladder muscles, the pelvic floor, and the sphincter — for "total" bladder control day and night, without limiting water intake, pelvic exercises or prescription pills. (The manufacturer's own label describes the formula more broadly as supporting bladder control "in men and women" — the marketing positioning, which is what the product is sold on, is men; women are directed by the maker to its women's counterpart, Confitrol24.) The maker says results can start "in as little as 14 days," with results improving the longer it is taken daily; its trial ran eight weeks. The brand page opens with an endorsement quote from a doctor who is not named in the page text — we note that because endorsements you cannot identify carry no weight here.

Key Ingredients

The entire active formula is one proprietary blend: Urox® Proprietary Blend — 840 mg per daily serving (2 capsules). The blend total is published; per-ingredient amounts are not published — the maker's label lists each component's amount as not provided, because the blend is proprietary. (Any site that quotes you exact per-ingredient milligrams for this product is inventing them; they appear nowhere in the maker's pages or label.) The three components, with the maker's own descriptions:

• Cratevox™ (Crateva nurvala stem bark extract) — the maker calls it "Bladder-Control Nutrient #1," used for centuries for bladder support; the maker says a recent study showed Crataeva increased both bladder tone and bladder capacity, and that Cratevox™ helps reduce urges and promotes a feeling of complete relief after urinating.
• Lindera Aggregata (root extract) — "Bladder-Control Nutrient #2," described by the maker as an "anti-aging" herb for the bladder that supports age-related bladder function.
• Horsetail (Equisetum arvense aerial parts extract) — "Bladder-Control Nutrient #3," with anti-inflammatory properties the maker calls key for healthy bladder function; the maker says studies show Crataeva and Horsetail combined significantly reduce bathroom visits.

Inactive ingredients, from the manufacturer's label (not stated on the marketing pages): HPMC (capsule), rice flour, silica. Urox® and Cratevox® are trademarks of Seipel Group Pty Ltd of Australia — the blend is a licensed ingredient, not a Leading Edge Health invention.

What We Like

• The evidence is at blend level, at the product's dose. The maker reports a trial of the exact proprietary blend in the bottle, taken at the same 840 mg daily dose the label directs — the strongest evidence tier short of a trial published under the Incontinix name itself.
• The trial's reported design is the right one — 150 volunteers, eight weeks, double-blind, placebo-controlled, published in a named journal (BMC Complementary Medicine and Therapies), per the maker.
• The reported outcomes are the ones that matter — overall urgency reduced by 62%, leaks cut in half, 60% of participants back to normal daytime frequency, about 25% no longer racing to the bathroom at night, and 23% totally symptom-free at eight weeks, as the maker reports them.
• A clear, published daily regimen — 2 capsules each morning; one 60-capsule bottle is a full 30-day supply. No ambiguity about how to take it.
• The trial course fits the guarantee — the 8-week course is 2 bottles, inside the 67-day return window, so a fair trial is genuinely refundable if you order and start promptly.

Good to Know

• The trial is the maker's report of it. Everything above comes from the maker's own pages. The maker does not publish the trial's sponsor or funder, a registration number, or a full citation (authors, year) on its product pages, and does not state the sex breakdown of the 150 volunteers. Read the results as the maker's account of a real-structured trial, not as independently verified findings.
• "Tested in 14 clinical trials" appears on the maker's brand and store pages — but only one trial is described anywhere. The other 13 are not named, described or cited. Similarly, the "24 global patents" the maker cites belong to the Urox® blend's developer, Seipel Group (the label lists Leading Edge Health as distributor), and the same patented blend is sold under other companies' brand names — none of which the maker's marketing mentions.
• The label quietly doubles the first month. The marketing pages say 2 capsules daily, full stop. The manufacturer's own label adds: "For faster effects; take 2 capsules twice daily for the first month of use" — a doubled regimen under which a bottle lasts 15 days, not 30. It appears in no marketing copy.
• The maker's pages disagree on what the 62% measures. The brand page ties 62% to reduced urgency; the maker's retail store page ties the same figure to reduced bathroom visits. By our source rule the brand page wins: 62% is the urgency figure. The retail page also inflates two claims beyond the brand page ("100% improvement in quality of life," "100% control over your bladder") — neither appears on the brand page, and we do not repeat them as findings.
• No warnings or exclusions are published — no side-effect list and no medication cautions appear anywhere in the maker's marketing for a product aimed squarely at older men, many of whom take prescription medication.
• Carelessness flags: the maker's own store page repeatedly misspells the product's name ("Inctontinix"), and the brand page misspells Crataeva once. Neither changes the formula; both are worth noticing in a maker asking for trust.

Who Should Not Use It

The maker publishes no exclusion list for Incontinix — no warnings, side-effect list, or pregnancy or medication cautions appear on the brand page, the maker's store page or its retail store. Its safety language is entirely positive: the maker says the formula was tested "without ANY reported negative side-effects." The only cautionary text in the maker's own materials is generic label boilerplate: consult your healthcare practitioner before using this or any such product, and keep out of reach of children. The label also carries the standard FDA disclaimer — these statements have not been evaluated by the Food and Drug Administration, and this product is not intended to diagnose, treat, cure or prevent any disease. Bladder symptoms can also signal conditions that need medical assessment in their own right. If you take prescription medication, manage a prostate or any other medical condition, or your symptoms are new, worsening or accompanied by pain or blood, talk to a doctor before relying on any supplement — the maker provides no guidance on any of this. Women: this product is marketed to men; the maker's counterpart formula for women is Confitrol24, reviewed on this store.

Where to Buy

Buy only from the official site so the guarantee applies: the official Incontinix store. One bottle is $59.99 (MSRP $69.99) on the maker's store page, or 4 interest-free payments of $15.00 on the brand page. The maker offers 1-, 2- and 3-month packs (instalments of 4 × $25.00 and 4 × $32.50 respectively on the brand page), but the multi-pack totals are not published as text on the maker's pages, so check the full price at checkout — and note there is no 6-bottle pack, whatever third-party sites claim. The maker-reported trial course is 8 weeks, i.e. 2 bottles at the standard dose, which fits inside the 67-day guarantee window if you start promptly. Disclosure: if you buy through our link, we may earn a commission at no extra cost to you.

FAQ

Has Incontinix been clinically tested?
The maker reports that the Urox® blend — the product's entire active formula — was tested in an 8-week, double-blind, placebo-controlled study of 150 volunteers, published in BMC Complementary Medicine and Therapies, at the same 840 mg daily dose the product delivers. Reported results include urgency reduced by 62%, leaks cut in half, and 23% of volunteers totally symptom-free. The maker does not publish the trial's sponsor or a full citation on its product pages.

How do I take it, and how long does it take to work?
Two capsules each morning; one bottle (60 capsules) is a 30-day supply. The maker says results can start in as little as 14 days, but its trial ran eight weeks and measured outcomes across that period — judge it on the trial's timeframe. (The manufacturer's label also mentions an optional doubled dose for the first month, which the marketing pages never mention; at that dose a bottle lasts 15 days.)

How much does it cost?
$59.99 per bottle (MSRP $69.99). The maker sells 1-, 2- and 3-month packs but does not publish multi-pack totals as text on its pages; check the total at checkout. There is no 6-bottle pack.

Does the guarantee cover a full trial?
Yes, with prompt ordering. The trial course is 8 weeks (2 bottles) and the guarantee window is 67 days from delivery, so a promptly started trial finishes inside the window.

Is Incontinix for women too?
The manufacturer label describes the blend as supporting bladder control "in men and women," but every maker marketing page positions Incontinix for men, and the maker directs women to its women's formula. On this store, women should look at Confitrol24 — the same Urox® blend in the maker's women's product, reviewed separately.

Are there side effects or people who should not take it?
The maker reports no negative side effects in the studies and publishes no side-effect list, warnings or exclusions anywhere in its marketing. If you take prescription medication or manage a medical condition, consult a doctor first.

Also Consider

• Confitrol24 — the same patented Urox® blend in the maker's women's bladder formula: the counterpart product for women, with the same maker-reported trial behind it, reviewed separately on this store.

Last reviewed: October 2026